
What We’re Reading: PBM Probe Stalls; CA’s Endemic Policy; Recalled Infant Formulas
A proposed probe of pharmacy benefit managers (PBMs) by the Federal Trade Commission did not win enough votes to go forward; California exits the crisis phase of the pandemic; Abbott infant formula has been recalled after 1 death.
FTC PBM Probe Will Not Move Forward
With a vote that failed to reach a consensus, the Federal Trade Commission (FTC) halted a probe into whether reimbursement rates set by pharmacy benefit managers (PBMs) unfairly favor affiliated pharmacies at the expense of independent or specialty ones,
California Moves to COVID-19 "Endemic"
California has become the first state to adopt an endemic virus policy against COVID-19, which includes emphasizing prevention and quickly responding to outbreaks as opposed to mandated masking and business shutdowns, according to
Popular Infant Formula Recalled
The FDA has warned parents not to use 3 powdered infant formulas manufactured by an Abbott plant in Michigan as they have been tied with bacterial contamination,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.